Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 54,500 | 7,600 | -35,600 | -26,000 | 62,700 |
| Depreciation Amortization | 113,700 | 85,000 | 56,600 | 27,300 | 63,100 |
| Income taxes - deferred | -1,100 | -5,700 | -1,300 | -11,400 | 8,600 |
| Accounts receivable | -8,200 | -18,600 | 44,600 | 141,600 | -94,200 |
| Accounts payable and accrued liabilities | 16,500 | 2,500 | 42,600 | 4,200 | -7,000 |
| Other Working Capital | -58,400 | -74,200 | 26,000 | 104,400 | -119,300 |
| Other Operating Activity | 71,000 | 69,300 | -63,900 | -135,300 | 127,900 |
| Operating Cash Flow | $188,000 | $65,900 | $69,000 | $104,800 | $41,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -86,900 | -50,800 | -35,500 | -21,400 | -69,500 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -827,700 |
| Other Investing Activity | -10,000 | -10,000 | -10,000 | 0 | 0 |
| Investing Cash Flow | $-96,900 | $-60,800 | $-45,500 | $-21,400 | $-897,200 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 118,700 | 130,000 | 124,400 | 30,000 | 798,000 |
| Debt Repayment | -105,000 | -103,400 | -80,000 | -82,800 | -2,800 |
| Common Stock Issued | N/A | 5,700 | 4,600 | 900 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -100 |
| Other Financing Activity | -49,600 | -10,300 | -7,300 | -6,500 | -6,400 |
| Financing Cash Flow | $-35,900 | $22,000 | $41,700 | $-58,400 | $788,700 |
| Exchange Rate Effect | 400 | -100 | N/A | N/A | -200 |
| Beginning Cash Position | 112,400 | 112,400 | 112,400 | 112,400 | 179,300 |
| End Cash Position | 168,000 | 139,400 | 177,600 | 137,400 | 112,400 |
| Net Cash Flow | $55,600 | $27,000 | $65,200 | $25,000 | $-66,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 188,000 | 65,900 | 69,000 | 104,800 | 41,800 |
| Capital Expenditure | -86,900 | -50,800 | -35,500 | -21,400 | -72,100 |
| Free Cash Flow | 101,100 | 15,100 | 33,500 | 83,400 | -30,300 |